surmount-1 trial tirzepatide weight loss non-diabetic Gastrointestinal tolerability and reduction associated with in adults with obesity or overweight with and without type 2 diabetes in the SURMOUNT‐1 to ‐4 trials - Rubino - 2025 tirzepatide maximum weight loss surmount

muciniphila administration can ameliorate inflammatory bowel diseases (IBD) or delay colitis-associated tumorigenesis in mice (Wang et al., 2020

Insurers face higher costs, legitimate patients encounter access barriers, and regulatory frameworks struggle to adapt quickly.

PR FYHN is a bridge connecting health information providers to BIPOC communities in a trusted environment

A personalized treatment plan is helpful for confronting the source of your chief health concerns

Yes, ashwagandha can generally be taken with vitamin D when taken as recommended

In November of 2023, Jelly Roll was named the CMAs New Artist of the Year